<!DOCTYPE html>
<html lang="en">
    <head>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <link rel="icon" type="image/x-icon" href="/favicon.ico" />
    <link rel="shortcut icon" type="image/x-icon" href="/favicon.ico" />
    <title>//sndbx.be is not science</title>
        <style type="text/css" title="layout">
		  @import "../../static/css/solarized_dark.css";
          @import "../../static/css/style.css";
@import "../../static/css/jquery.fancybox.css";        </style>
        <script src="../../static/scripts/jquery-1.7.2.min.js"></script>
		<!-- Using MathJax, with the delimiters $ -->
		<!-- Conflict with pygments for the .mo and .mi -->
		<script type="text/x-mathjax-config">
		  MathJax.Hub.Config({
		  "HTML-CSS": {
		  styles: {
		  ".MathJax .mo, .MathJax .mi": {color: "black ! important"}}
		  },
		  tex2jax: {inlineMath: [['$','$'], ['\\\\(','\\\\)']],processEscapes: true},
		  TeX: { equationNumbers: { autoNumber: "AMS" } }
		  });
		</script>

	   <script type="text/javascript" src="http://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS_HTML"></script>
        <script src="../../static/scripts/jquery.fancybox.pack.js"></script>
        <script type="text/javascript">
            $(document).ready(function() {
                $('.fancybox').fancybox({
                openEffect  : 'none',
                closeEffect : 'none',
                padding : 0,
                beforeLoad: function() {
                    var el, id = $(this.element).data('title-id');

                    if (id) {
                        el = $('#' + id);
                    
                        if (el.length) {
                            this.title = el.html();
                        }
                    }
                },
                afterShow: function() {
                    $(".fancybox-title").wrapInner('<div />').show();
                    
                    $(".fancybox-wrap").hover(function() {
                        $(".fancybox-title").show();
                    }, function() {
                        $(".fancybox-title").hide();
                    });
                },
                helpers : {
                    title: {
                        type: 'over'
                    }
                }

                });
            });
        </script>
    </head>
    <body>

        <div id="container">
        	<div id="header-wrapper">

				<div id="header">
					<h1><a href="../.." title="home">//sndbx.be</a></h1>
				</div>
				<div id='nav'>
					 <ul>
						<li style="border-left: none;" ><a  class="active"  href="../../">blog</a></li>
						<li><a  href="../../showcase/">showcase</a></li>
						<li><a  href="../../about/">about</a></li>
					</ul>
				</div>
			</div>
			<div id="my_fixable_header">...</div>
            <div id="mainContent"><h1>Analysis of cytokine profiling from liver metastasis samples</h1>
<div id="printheader"><h2>Emiliano Izquierdo</h2></div><div id="wdate">&mdash; written on Wednesday, July 24, 2013</div>	<p>Cytokines are signaling peptides recently found to be important in the tumor microenvironmet determining tumour invasion and the spatial distribution of immune cell infiltrates.</p>
<h2 id="sample-preparation-and-cytokine-measurements">Sample preparation and cytokine measurements</h2>
<p>Biopsy samples from patients are cryosectioned. Subsequentially, specimens are immunohistochemically analyzed for different immune cell markers (CD3<sup>+</sup>, CD8<sup>+</sup>, granzyme B<sup>+</sup>, FOXP3, NKp46 and CD68<sup>+</sup>). Full tissue sections are imaged and evaluated and different regions are defined: liver, adjacent liver, invasive  margin (500 um width on each side of the border between malignant cells and peritumoral stroma), and liver metastases. Tissue sections were disected and different compartments were treated separately for lysis and posterior multiplexed cytokine detection by luminex assay. (flow cytometry-based method utilizing magnetic microspheres conjugated with monoclonal antibodies using the BioPlex 200 platform with HRF (Bio-Rad, USA), incorporating Luminex xMAP? technology, and validated custom plexes for simultaneous measurement <a href="#Krzystek-Korpacka2013">??</a>)</p>
<h2 id="overall-distribution-of-absolute-measurements-in-concentration">Overall distribution of absolute measurements in concentration</h2>
<p>We first grouped the data by region (<strong>L</strong> Liver, <strong>AL</strong> Adjacent liver, <strong>IM</strong> Invasive margin, <strong>LM</strong> Liver Metastasis, and Supernatant) and afterwards by gene, thus we see the distribution of the measurements in a boxplot across al patients</p>
<p><a class="fancybox" rel="figures" href="/static/images/tiga/boxplot-ck-profile-region-patients_log10.png" title="Cytokine profiles" target="_blank"><img src="/static/images/tiga/boxplot-ck-profile-region-patients_log10.png" style="background-color:#fff; max-width: 90%;" alt="" /></a>
<p class="caption" style="width: 90%;"><strong>Figure 1.</strong> Cytokine profiles</p></p>
<p>We then asked which genes in each region have a concentration over 20 pM. We filtered genes with a median cytokine concentration among all the patients was over 20pM.</p>
<!this is the table 1>

<table border="1" cellpadding="4" cellspacing="0" align="center" style="font-size:0.7em;">
<tr><td colspan="4">Region</td></tr>
<tr><td>L</td><td>AL</td><td>IM</td><td>LM</td></tr>
<tr><td style="background:#00B4A1">IFNG</td><td style="background:#00B4A1">VEGFA</td><td style="background:#00B4A1">IFNG</td><td style="background:#00B4A1">IFNG</td></tr>
<tr><td style="background:#00B4A1">CSF3</td><td style="background:#00B4A1">IFNG</td><td style="background:#20B5A1">CCL11</td><td style="background:#37B8A1">CCL7</td></tr>
<tr><td style="background:#37B8A1">CCL27</td><td style="background:#20B5A1">CCL7</td><td style="background:#20B5A1">CCL7</td><td style="background:#40B9A1">CCL27</td></tr>
<tr><td style="background:#4EBCA1">TNFSF10</td><td style="background:#37B8A1">CCL2</td><td style="background:#37B8A1">SCF</td><td style="background:#47BBA1">Il6</td></tr>
<tr><td style="background:#4EBCA1">CXCL1</td><td style="background:#40B9A1">CCL27</td><td style="background:#37B8A1">IL12A</td><td style="background:#47BBA1">CCL11</td></tr>
<tr><td style="background:#55BEA1">CCL4</td><td style="background:#40B9A1">Il8</td><td style="background:#40B9A1">CCL27</td><td style="background:#4EBCA1">SCF</td></tr>
<tr><td style="background:#5ABFA1">PDGFB</td><td style="background:#55BEA1">CXCL1</td><td style="background:#47BBA1">PDGFB</td><td style="background:#4EBCA1">CSF-1</td></tr>
<tr><td style="background:#60C0A1">CSF-1</td><td style="background:#5ABFA1">CSF-1</td><td style="background:#55BEA1">CSF-1</td><td style="background:#60C0A1">TNFSF10</td></tr>
<tr><td style="background:#6FC4A1">CXCL12</td><td style="background:#5ABFA1">PDGFB</td><td style="background:#73C6A1">TNFSF10</td><td style="background:#65C2A1">IFNA2</td></tr>
<tr><td style="background:#6FC4A1">CXCL10</td><td style="background:#5ABFA1">CCL4</td><td style="background:#73C6A1">Il18</td><td style="background:#65C2A1">Il18</td></tr>
<tr><td style="background:#73C6A1">Il18</td><td style="background:#6AC3A1">Il18</td><td style="background:#73C6A1">IFNA2</td><td style="background:#65C2A1">FGF2</td></tr>
<tr><td style="background:#73C6A1">IFNA2</td><td style="background:#6AC3A1">TNFSF10</td><td style="background:#7CC8A1">CXCL12</td><td style="background:#6AC3A1">IL12A</td></tr>
<tr><td style="background:#80C9A1">Il3</td><td style="background:#73C6A1">CXCL12</td><td style="background:#80C9A1">CCL4</td><td style="background:#78C7A1">CCL4</td></tr>
<tr><td style="background:#88CCA1">Il12</td><td style="background:#73C6A1">IFNA2</td><td style="background:#80C9A1">CCL2</td><td style="background:#78C7A1">Il3</td></tr>
<tr><td style="background:#88CCA1">IL2RA</td><td style="background:#84CBA1">Il3</td><td style="background:#84CBA1">VEGFA</td><td style="background:#80C9A1">CXCL12</td></tr>
<tr><td style="background:#88CCA1">CXCL9</td><td style="background:#84CBA1">CXCL10</td><td style="background:#84CBA1">Il3</td><td style="background:#8CCDA1">CCL5</td></tr>
<tr><td style="background:#8FCEA1">CCL5</td><td style="background:#8CCDA1">FGF2</td><td style="background:#84CBA1">CXCL1</td><td style="background:#8FCEA1">IL2RA</td></tr>
<tr><td style="background:#8FCEA1">FGF2</td><td style="background:#8CCDA1">Il12</td><td style="background:#88CCA1">FGF2</td><td style="background:#8FCEA1">Il12</td></tr>
<tr><td style="background:#A6D7A1">CLEC11A</td><td style="background:#8FCEA1">IL2RA</td><td style="background:#93D0A1">Il12</td><td style="background:#93D0A1">CXCL1</td></tr>
<tr><td style="background:#AFDBA1">HGF</td><td style="background:#AAD8A1">CCL5</td><td style="background:#96D1A1">IL2RA</td><td style="background:#A3D6A1">CCL2</td></tr>
<tr><td style="background:#B2DCA1">Il16</td><td style="background:#ADD9A1">CXCL9</td><td style="background:#9AD2A1">Il8</td><td style="background:#B2DCA1">Il16</td></tr>
<tr><td style="background:#D0E8A1">IL1RN</td><td style="background:#B5DDA1">CLEC11A</td><td style="background:#A6D7A1">CCL5</td><td style="background:#B2DCA1">VEGFA</td></tr>
<tr><td style="background:#D2E9A1">VCAM1</td><td style="background:#BEE0A1">Il16</td><td style="background:#ADD9A1">CXCL10</td><td style="background:#B2DCA1">CXCL10</td></tr>
<tr><td style="background:#D2E9A1">ICAM1</td><td style="background:#BEE0A1">HGF</td><td style="background:#C0E2A1">Il16</td><td style="background:#B2DCA1">Il8</td></tr>
<tr><td style="background:#FFFFA1">MIF</td><td style="background:#D2E9A1">IL1RN</td><td style="background:#C3E3A1">CXCL9</td><td style="background:#C0E2A1">CXCL9</td></tr>
<tr><td style="background:#FFFFFF">&nbsp;</td><td style="background:#D5EAA1">ICAM1</td><td style="background:#C8E5A1">ICAM1</td><td style="background:#C8E5A1">HGF</td></tr>
<tr><td style="background:#FFFFFF">&nbsp;</td><td style="background:#DCEEA1">VCAM1</td><td style="background:#CDE7A1">HGF</td><td style="background:#D2E9A1">ICAM1</td></tr>
<tr><td style="background:#FFFFFF">&nbsp;</td><td style="background:#F8FBA1">MIF</td><td style="background:#D7ECA1">IL1RN</td><td style="background:#D5EAA1">IL1RN</td></tr>
<tr><td style="background:#FFFFFF">&nbsp;</td><td style="background:#FFFFFF">&nbsp;</td><td style="background:#DEEFA1">VCAM1</td><td style="background:#DCEEA1">VCAM1</td></tr>
<tr><td style="background:#FFFFFF">&nbsp;</td><td style="background:#FFFFFF">&nbsp;</td><td style="background:#E3F1A1">CLEC11A</td><td style="background:#F4F9A1">MIF</td></tr>
<tr><td style="background:#FFFFFF">&nbsp;</td><td style="background:#FFFFFF">&nbsp;</td><td style="background:#F8FBA1">MIF</td><td style="background:#FAFCA1">CLEC11A</td></tr>
</table>

<p class="caption" style="width: 90%; margin-top: 5px; margin-bottom: 5px;"><strong>Table 1.</strong> Cytokines with median concentration above 20 pM, (ascending order)</p>

<!this is the table 2>

<table border="1" cellpadding="4" cellspacing="0" align="center" style="font-size:0.7em;">
<tr><td style="background:#00B4A1">ICAM1</td><td style="background:#80C9A1">Il12</td><td style="background:#8CCDA1">FGF2</td><td style="background:#ADD9A1">Il18</td><td style="background:#BEE0A1">CCL5</td><td style="background:#DEEFA1">Il8</td></tr>
<tr><td style="background:#4EBCA1">IFNA2</td><td style="background:#84CBA1">CCL7</td><td style="background:#8CCDA1">CSF3</td><td style="background:#ADD9A1">HGF</td><td style="background:#C8E5A1">MIF</td><td style="background:#F0F7A1">CLEC11A</td></tr>
<tr><td style="background:#6FC4A1">CCL27</td><td style="background:#88CCA1">Il16</td><td style="background:#93D0A1">CSF-1</td><td style="background:#B5DDA1">CCL11</td><td style="background:#CDE7A1">CCL4</td><td style="background:#FFFFA1">Il6</td></tr>
<tr><td style="background:#73C6A1">Il3</td><td style="background:#88CCA1">VCAM1</td><td style="background:#96D1A1">SCF</td><td style="background:#B8DEA1">VEGFA</td><td style="background:#CDE7A1">CXCL10</td><td style="background:#FFFFFF">&nbsp;</td></tr>
<tr><td style="background:#73C6A1">IL2RA</td><td style="background:#88CCA1">IFNG</td><td style="background:#9AD2A1">IL12A</td><td style="background:#BBDFA1">CXCL1</td><td style="background:#D2E9A1">CXCL9</td><td style="background:#FFFFFF">&nbsp;</td></tr>
<tr><td style="background:#80C9A1">PDGFB</td><td style="background:#8CCDA1">CXCL12</td><td style="background:#9DD3A1">IL1RN</td><td style="background:#BEE0A1">TNFSF10</td><td style="background:#D5EAA1">CCL2</td><td style="background:#FFFFFF">&nbsp;</td></tr>
</table>

<p class="caption" style="width: 90%; margin-top: 5px;"><strong>Table 2.</strong> Unique cytokines by coefficient of variation</p>

<p><a class="fancybox" rel="figures" href="/static/images/tiga/hist_cytokine_concentrations.png" title="Histogram of cytokine concentrations" target="_blank"><img src="/static/images/tiga/hist_cytokine_concentrations.png" style="background-color:#fff; max-width: 90%;" alt="" /></a>
<p class="caption" style="width: 90%;"><strong>Figure 2.</strong> Histogram of cytokine concentrations</p></p>
<p><a class="fancybox" rel="figures" href="/static/images/tiga/ecdf_kstest.png" title="mpirical CDF" target="_blank"><img src="/static/images/tiga/ecdf_kstest.png" style="background-color:#fff; max-width: 90%;" alt="click to enlarge" /></a>
<p class="caption" style="width: 90%;"><strong>Figure 3.</strong> Empirical CDF comparison with standard normal distribution, p values come from <a href="http://en.wikipedia.org/wiki/Kolmogorov%E2%80%93Smirnov_test">Kolmogorov-Smirnoff</a> test at alpha = 0.05, hypotesis are rejected despite their great resemblance, and I am not sure why, when I perform the 2 sample test <code>kstest2</code> with normally desitributed random values with mean 0 and std 1, the tests fails to reject the hypotesis that they come from the same distribution....wierd!</p></p>
<p><a class="fancybox" rel="figures" href="/static/images/tiga/boxplot-ck-coeff_variation-region-patients_log10.png" title="Coefficient of variation sorted" target="_blank"><img src="/static/images/tiga/boxplot-ck-coeff_variation-region-patients_log10.png" style="background-color:#fff; max-width: 90%;" alt="" /></a>
<p class="caption" style="width: 90%;"><strong>Figure 3.</strong> Cytokine concentrations sorted by coefficient of variation</p></p>
<h2 id="coefficient-of-variation-for-lognormally-distributed-data">Coefficient of variation for lognormally distributed data</h2>
<p>\begin{equation}
   \hat{C}_v = \sqrt{e^{\sigma^2} -1}
\end{equation}</p>
<p><a class="fancybox" rel="figures" href="/static/images/tiga/boxplot-ck-coeff_variation-all-regions.png" title="Coefficient of variation sorted for all regions" target="_blank"><img src="/static/images/tiga/boxplot-ck-coeff_variation-all-regions.png" style="background-color:#fff; max-width: 90%;" alt="" /></a>
<p class="caption" style="width: 90%;"><strong>Figure 4.</strong> Cytokine concentrations sorted by coefficient of variation for all regions (L,AL,IM,LM)</p></p>
<p>boxplot-ck-coeff_variation-all-regions-single-ck.png</p>
<p><a class="fancybox" rel="figures" href="/static/images/tiga/boxplot-ck-coeff_variation-all-regions-single-ck.png" title="Coefficient of variation sorted for all regions" target="_blank"><img src="/static/images/tiga/boxplot-ck-coeff_variation-all-regions-single-ck.png" style="background-color:#fff; max-width: 90%;" alt="" /></a>
<p class="caption" style="width: 90%;"><strong>Figure 5.</strong> Cytokine concentrations sorted by coefficient of variation for all regions (L,AL,IM,LM)</p></p>
<p><a class="fancybox" rel="figures" href="/static/images/tiga/rank_corr_matrix.png" title="Rank correlations matrix" target="_blank"><img src="/static/images/tiga/rank_corr_matrix.png" style="background-color:#fff; max-width: 90%;" alt="" /></a>
<p class="caption" style="width: 90%;"><strong>Figure 6.</strong> Correlation matrix for cytokine levels across patients</p></p>
<p><a class="fancybox" rel="figures" href="/static/images/tiga/ck_corr_network.png" title="Network of correlations" target="_blank"><img src="/static/images/tiga/ck_corr_network.png" style="background-color:#fff; max-width: 90%;" alt="" /></a>
<p class="caption" style="width: 90%;"><strong>Figure 7.</strong> Network for cytokine correlating in levels across patients, I used a threshold for corelation of &gt; 0.75 and &lt; -0.6, </p></p>
<p><a class="fancybox" rel="figures" href="/static/images/tiga/ck_corr_network-07.png" title="Network of correlations" target="_blank"><img src="/static/images/tiga/ck_corr_network-07.png" style="background-color:#fff; max-width: 90%;" alt="" /></a>
<p class="caption" style="width: 90%;"><strong>Figure 8.</strong> Network for cytokine correlating in levels across patients, I used a threshold for corelation of &gt; 0.7 and &lt; -0.6, </p></p>
<p>When we observe the cytokine profiles for different cytokines we see that some of them have both clear patterns of localized concentration and low or high variability. The aim of ana;lysing this kind of data is to integrate it into a theoretical model. We can observe that two highly variable cytokine profiles correlate, this means that the variability is coupled in a system and it is not independent from other variable cks, we can also see correlation of mildly variable together with low variable cks. For example the correlation between VEGFA and IL8 is remarkable, with a spearman ncorrelation coefficient of 0.84, being IL8 one of the highly variable cytokines.</p>
<p>As we ask for correlation of cytokine in levels we also want to concentrate in those that are still variable but does not show any correlation with other ones. If each one of the cytokines is a feature, then maybe we can use feature reduction to know which of the genes are the most variable, then concentrate on clustering the patients given these cytokines. another approach could be to use Principal component analysis and then from there cluster the patients, however there we loose the info of which genes are the most determining ones.</p>
<p>Another problem is the factr that we lack values from some of the cytokines, and I still don't know hwat to do with those. One option is to take missing values from the most highly correlated cytokines, using the neighborhood from other patients.</p>
<h2 id="missing-data-imputation">Missing data imputation</h2>
<p><code>knnimpute(Data, k)</code> replaces NaNs in Data with a weighted mean of the k nearest-neighbor columns. The weights are inversely proportional to the distances from the neighboring columns.</p>
<p><a class="fancybox" rel="figures" href="/static/images/tiga/Ck_profiiles_clustergram_rows_euc-ward_spear-weight.png" title="Network of correlations" target="_blank"><img src="/static/images/tiga/Ck_profiiles_clustergram_rows_euc-ward_spear-weight.png" style="background-color:#fff; max-width: 90%;" alt="" /></a>
<p class="caption" style="width: 90%;"><strong>Figure 9.</strong> <code>Clustergram</code> function in MATLAB performs biclustering. After data impuatation with NN using weighted with k=2 we parformed clustering for all the different available samples, we also excluded ICAM1 beacuse it lacked a lot of measurements. For the distances and linkage we used euclidean and ward for rows, and spearman and weighted for columns. The values are standarized to the mean and std of the row. The question here since we already see that the clusetering already recovers very well the different spatial distributons, separating L/AL from IM/LM, this already tells us that there are some genes especific for the different cell types localized at the different regions.</p></p>
<p><a class="fancybox" rel="figures" href="/static/images/tiga/Spatial_Ck_profiiles_clustergram_rows_euc-ward2.png" title="Network of correlations" target="_blank"><img src="/static/images/tiga/Spatial_Ck_profiiles_clustergram_rows_euc-ward2.png" style="background-color:#fff; max-width: 90%;" alt="" /></a>
<p class="caption" style="width: 90%;"><strong>Figure 9.</strong> <code>Clustergram</code> function in MATLAB performs biclustering. After data impuatation with NN using weighted with k=2 we parformed clustering for all the different available samples, we also excluded ICAM1 beacuse it lacked a lot of measurements. For the distances and linkage we used euclidean and ward for rows, and spearman and weighted for columns. The values are standarized to the mean and std of the row. The question here since we already see that the clusetering already recovers very well the different spatial distributons, separating L/AL from IM/LM, this already tells us that there are some genes especific for the different cell types localized at the different regions.</p></p>
<!SICARII (SIngle Cell ARtificial IntelIgence) also from the plural of sicarius, use developmental principles to build biological machines with emergent properties and autoorganization.>
	<h1>References</h1>
		<div id="bibliography" style="font-size:0.9em;">
		    <ol>
			    <li id="Adra2010">Adra Salem, Sun Tao, MacNeil Sheila, Holcombe Mike, Smallwood Rod. (2010) <a href=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2799518\&tool=pmcentrez\&rendertype=abstract>Development of a three dimensional multiscale computational model of the human epidermis.</a> <em>PloS one</em> 5: e8511.
			    </li>
			    <li id="Albert1980">Albert Arthur, Freedman Marvin, Perelson Alan S.. (1980) <a href=http://linkinghub.elsevier.com/retrieve/pii/0025556480901200>Tumors and the immune system the effects of a tumor growth modulator.</a> <em>Mathematical Biosciences</em> 50: 25--58.
			    </li>
			    <li id="Baker2012">Baker Michelle, Denman-Johnson Sarah, Brook Bindi S, Gaywood Ian, Owen Markus R. (2012) <a href=http://www.ncbi.nlm.nih.gov/pubmed/23002057>Mathematical modelling of cytokinemediated inflammation in rheumatoid arthritis.</a> <em>Mathematical medicine and biology : a journal of the IMA</em> &nbsp;: 1--27.
			    </li>
			    <li id="Balkwill2004">Balkwill Fran. (2004) <a href=http://www.ncbi.nlm.nih.gov/pubmed/15229479>Cancer and the chemokine network.</a> <em>Nature reviews. Cancer</em> 4: 540--50.
			    </li>
			    <li id="Belardelli2002">Belardelli Filippo, Ferrantini Maria. (2002) <a href=&nbsp;>Cytokines as a link between innate and adaptive antitumor immunity adaptive responses to tumors  the role of cytokines.</a> <em>Trends in immunology</em> 23: 201--208.
			    </li>
			    <li id="Busse2010">Busse Dorothea, de la Rosa Maurus, Hobiger Kirstin, Thurley Kevin, Flossdorf Michael, Scheffold Alexander, Hofer Thomas. (2010) <a href=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2840293\&tool=pmcentrez\&rendertype=abstract>Competing feedback loops shape IL2 signaling between helper and regulatory T lymphocytes in cellular microenvironments.</a> <em>Proceedings of the National Academy of Sciences of the United States of America</em> 107: 3058--63.
			    </li>
			    <li id="Cavaillon1994">Cavaillon J M. (1994) <a href=&nbsp;>Cytokines and macrophages.</a> <em>Biomedicine \& Pharmacotherapy</em> 48: 445--453.
			    </li>
			    <li id="Dominguez-Huttinger2013">Dominguez-Huttinger Elisa, Ono Masahiro, Barahona Mauricio, Tanaka Reiko J. (2013) <a href=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3638487\&tool=pmcentrez\&rendertype=abstract>Risk factordependent dynamics of atopic dermatitis modelling multiscale regulation of epithelium homeostasis.</a> <em>Interface focus</em> 3: 20120090.
			    </li>
			    <li id="Dranoff2004">Dranoff Glenn. (2004) <a href=http://www.ncbi.nlm.nih.gov/pubmed/14708024>Cytokines in cancer pathogenesis and cancer therapy.</a> <em>Nature reviews. Cancer</em> 4: 11--22.
			    </li>
			    <li id="Dunlop2000">Dunlop Robert J, Chb M B, Campbell Colin W, Christopher St, C Princess Alice Hospice C W. (2000) <a href=&nbsp;>Cytokines and Advanced Cancer.</a> <em>Journal of Pain and Szmptom Management</em> 20: 214--232.
			    </li>
			    <li id="Dunn2002">Dunn Gavin P, Bruce Allen T, Ikeda Hiroaki, Old Lloyd J, Schreiber Robert D. (2002) <a href=&nbsp;>Cancer immunoediting  from immuno surveillance to tumor escape.</a> <em>Nature immunology</em> 3: 991--998.
			    </li>
			    <li id="Edelman2010">Edelman Lucas B, Eddy James a, Price Nathan D. (2010) <a href=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3157287\&tool=pmcentrez\&rendertype=abstract>In silico models of cancer.</a> <em>Wiley interdisciplinary reviews. Systems biology and medicine</em> 2: 438--59.
			    </li>
			    <li id="Feder-Mengus2008">Feder-Mengus Chantal, Ghosh Sourabh, Reschner Anca, Martin Ivan, Spagnoli Giulio C. (2008) <a href=http://www.ncbi.nlm.nih.gov/pubmed/18614399>New dimensions in tumor immunology what does 3D culture reveal.</a> <em>Trends in molecular medicine</em> 14: 333--40.
			    </li>
			    <li id="Ferrantini2008">Ferrantini Maria, Capone Imerio, Belardelli Filippo. (2008) <a href=http://www.ncbi.nlm.nih.gov/pubmed/18054517>Dendritic cells and cytokines in immune rejection of cancer.</a> <em>Cytokine \& growth factor reviews</em> 19: 93--107.
			    </li>
			    <li id="Fidler2002">Fidler Isaiah J. (2002) <a href=http://www.ncbi.nlm.nih.gov/pubmed/12492492>The organ microenvironment and cancer metastasis.</a> <em>Differentiation; research in biological diversity</em> 70: 498--505.
			    </li>
			    <li id="Frankenstein2006">Frankenstein Ziv, Alon Uri, Cohen Irun R. (2006) <a href=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1636025\&tool=pmcentrez\&rendertype=abstract>The immunebody cytokine network defines a social architecture of cell interactions.</a> <em>Biology direct</em> 1: 32.
			    </li>
			    <li id="Gabrilovich2012">Gabrilovich Dmitry I, Ostrand-Rosenberg Suzanne, Bronte Vincenzo. (2012) <a href=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3587148\&tool=pmcentrez\&rendertype=abstract>Coordinated regulation of myeloid cells by tumours.</a> <em>Nature reviews. Immunology</em> 12: 253--68.
			    </li>
			    <li id="Galon2006">Galon Jer^ome, Costes Anne, Sanchez-Cabo Fatima, Kirilovsky Amos, Mlecnik Bernhard, Lagorce-Pages Christine, Tosolini Marie, Camus Matthieu, Berger Anne, Wind Philippe, Zinzindohoue Franck, Bruneval Patrick, Cugnenc Paul-Henri, Trajanoski Zlatko, Fridman Wolf-Herman, Pages Franck. (2006) <a href=http://www.ncbi.nlm.nih.gov/pubmed/17008531>Type density and location of immune cells within human colorectal tumors predict clinical outcome.</a> <em>Science</em> 313: 1960--4.
			    </li>
			    <li id="Haining2012">Haining W Nicholas. (2012) <a href=http://www.ncbi.nlm.nih.gov/pubmed/22284416>The numerology of T cell functional diversity.</a> <em>Immunity</em> 36: 10--2.
			    </li>
			    <li id="Halama2011">Halama Niels, Braun Monika, Kahlert Christoph, Spille Anna, Quack Christian, Rahbari Nuh, Koch Moritz, Weitz Jurgen, Kloor Matthias, Zoernig Inka, Schirmacher Peter, Brand Karsten, Grabe Niels, Falk Christine S. (2011) <a href=http://www.ncbi.nlm.nih.gov/pubmed/21325295>Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines.</a> <em>Clinical cancer research</em> 17: 678--89.
			    </li>
			    <li id="Halama2011a">Halama Niels, Michel Sara, Kloor Matthias, Zoernig Inka, Benner Axel, Spille Anna, Pommerencke Thora, von Knebel Doeberitz Magnus, Folprecht Gunnar, Luber Birgit, Feyen Nadine, Martens Uwe M, Beckhove Philipp, Gnjatic Sacha, Schirmacher Peter, Herpel Esther, Weitz Juergen, Grabe Niels, Jaeger Dirk. (2011) <a href=http://www.ncbi.nlm.nih.gov/pubmed/21846824>Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy.</a> <em>Cancer research</em> 71: 5670--7.
			    </li>
			    <li id="Halama2009">Halama Niels, Michel Sara, Kloor Matthias, Zoernig Inka, Pommerencke Thora, von Knebel Doeberitz Magnus, Schirmacher Peter, Weitz Jurgen, Grabe Niels, Jager Dirk. (2009) <a href=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2935770\&tool=pmcentrez\&rendertype=abstract>The localization and density of immune cells in primary tumors of human metastatic colorectal cancer shows an association with response to chemotherapy.</a> <em>Cancer immunity</em> 9: 1.
			    </li>
			    <li id="Halama2013">Halama Niels, Spille Anna, Lerchl Tina, Brand Karsten, Herpel Esther, Welte Stefan, Keim Sophia, Lahrmann Bernd, Klupp Fee, Kahlert Christoph, Weitz Jurgen, Grabe Niels, Jaeger Dirk, Zoernig Inka. (2013) <a href=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3654605\&tool=pmcentrez\&rendertype=abstract>Hepatic metastases of colorectal cancer are rather homogeneous but differ from primary lesions in terms of immune cell infiltration.</a> <em>Oncoimmunology</em> 2: e24116.
			    </li>
			    <li id="Halama2012">Halama Niels, Zoernig Inka, Grabe Niels, Jaeger Dirk. (2012) <a href=&nbsp;>The local immunological microenvironment in colorectal cancer as a prognostic factor for treatment decisions in the clinic.</a> <em>Oncoimmunology</em> 1: 62--66.
			    </li>
			    <li id="Halama2010">Halama Niels, Zoernig Inka, Spille Anna, Michel Sara, Kloor Matthias, Grauling-Halama Silke, Westphal Kathi, Schirmacher Peter, Jager Dirk, Grabe Niels. (2010) <a href=http://www.ncbi.nlm.nih.gov/pubmed/21456345>Quantification of prognostic immune cell markers in colorectal cancer using whole slide imaging tumor maps.</a> <em>Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology</em> 32: 333--40.
			    </li>
			    <li id="Hanada2002">Hanada Toshitkatsu, Yoshimura Akihiko. (2002) <a href=http://www.ncbi.nlm.nih.gov/pubmed/14630206>Regulation of cytokine signaling and inflammation.</a> <em>Cytokine \& growth factor reviews</em> 13: 413--21.
			    </li>
			    <li id="Hao2012">Hao Ning-Bo, Lu Mu-Han, Fan Ya-Han, Cao Ya-Ling, Zhang Zhi-Ren, Yang Shi-Ming. (2012) <a href=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3385963\&tool=pmcentrez\&rendertype=abstract>Macrophages in tumor microenvironments and the progression of tumors.</a> <em>Clinical \& developmental immunology</em> 2012: 948098.
			    </li>
			    <li id="Janes2005">Janes Kevin a, Albeck John G, Gaudet Suzanne, Sorger Peter K, Lauffenburger Douglas a, Yaffe Michael B. (2005) <a href=http://www.ncbi.nlm.nih.gov/pubmed/16339439>A systems model of signaling identifies a molecular basis set for cytokineinduced apoptosis.</a> <em>Science (New York, N.Y.)</em> 310: 1646--53.
			    </li>
			    <li id="Jung2002">Jung Young D, Ahmad Syed a, Liu Wenbiao, Reinmuth Neils, Parikh Alexander, Stoeltzing Oliver, Fan Fan, Ellis Lee M. (2002) <a href=http://www.ncbi.nlm.nih.gov/pubmed/12027582>The role of the microenvironment and intercellular crosstalk in tumor angiogenesis.</a> <em>Seminars in cancer biology</em> 12: 105--12.
			    </li>
			    <li id="Karin2005">Karin Michael, Greten Florian R. (2005) <a href=http://www.ncbi.nlm.nih.gov/pubmed/16175180>NFkappaB linking inflammation and immunity to cancer development and progression.</a> <em>Nature reviews. Immunology</em> 5: 749--59.
			    </li>
			    <li id="Keim2012">Keim Sophia, Zoernig Inka, Spille Anna, Lahrmann Bernd, Brand Karsten, Herpel Esther, Grabe Niels, Jager Dirk, Halama Niels. (2012) <a href=&nbsp;>Sequential metastases of colorectal cancer Immunophenotypes and spatial distributions of infiltrating immune cells in relation to time and treatments.</a> <em>Oncoimmunology</em> &nbsp;: 593--599.
			    </li>
			    <li id="Kerkar2012">Kerkar Sid P, Restifo Nicholas P. (2012) <a href=http://www.ncbi.nlm.nih.gov/pubmed/22721837>Cellular constituents of immune escape within the tumor microenvironment.</a> <em>Cancer research</em> 72: 3125--30.
			    </li>
			    <li id="Khong2002">Khong Hung T, Restifo Nicholas P. (2002) <a href=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1508168\&tool=pmcentrez\&rendertype=abstract>Natural selection of tumor variants in the generation of tumor escape phenotypes.</a> <em>Nature immunology</em> 3: 999--1005.
			    </li>
			    <li id="Kim2013">Kim Yangjin, Boushaba Khalid. (2013) <a href=http://www.springerlink.com/index/10.1007/978-1-4614-1445-2>Regulation of Tumor Dormancy and Role of Microenvironment A Mathematica Model.</a> <em>&nbsp;</em> 734: 237--259.
			    </li>
			    <li id="Kim2010a">Kim Yangjin, Friedman Avner. (2010) <a href=http://www.ncbi.nlm.nih.gov/pubmed/19908100>Interaction of tumor with its microenvironment A mathematical model.</a> <em>Bulletin of mathematical biology</em> 72: 1029--68.
			    </li>
			    <li id="Kim2010">Kim Yangjin, Wallace Julie, Li Fu, Ostrowski Michael, Friedman Avner. (2010) <a href=http://www.ncbi.nlm.nih.gov/pubmed/19902212>Transformed epithelial cells and fibroblastsmyofibroblasts interaction in breast tumor a mathematical model and experiments.</a> <em>Journal of mathematical biology</em> 61: 401--21.
			    </li>
			    <li id="Klinke2012">Klinke David J, Cheng Ning, Chambers Emily. (2012) <a href=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3373264\&tool=pmcentrez\&rendertype=abstract>Quantifying crosstalk among interferongamma interleukin12 and tumor necrosis factor signaling pathways within a TH1 cell model.</a> <em>Science signaling</em> 5: ra32.
			    </li>
			    <li id="Korkaya2011">Korkaya Hasan, Liu Suling, Wicha Max S. (2011) <a href=&nbsp;>Review series Breast cancer stem cells  cytokine networks  and the tumor microenvironment.</a> <em>The Journal of Clinical Investigation</em> 121: &nbsp;.
			    </li>
			    <li id="Krzystek-Korpacka2013">Krzystek-Korpacka Malgorzata, Diakowska Dorota, Kapturkiewicz Bartosz, Bębenek Marek, Gamian Andrzej. (2013) <a href=http://www.ncbi.nlm.nih.gov/pubmed/23726839>Profiles of circulating inflammatory cytokines in colorectal cancer CRC high cancer risk conditions and health are distinct Possible implications for CRC screening and surveillance.</a> <em>Cancer letters</em> 337: 107--14.
			    </li>
			    <li id="Levine2000">Levine H a, Sleeman B D, Nilsen-Hamilton M. (2000) <a href=http://www.ncbi.nlm.nih.gov/pubmed/11121821>A mathematical model for the roles of pericytes and macrophages in the initiation of angiogenesis I The role of protease inhibitors in preventing angiogenesis.</a> <em>Mathematical biosciences</em> 168: 77--115.
			    </li>
			    <li id="Lewis2006">Lewis Claire E, Pollard Jeffrey W. (2006) <a href=http://www.ncbi.nlm.nih.gov/pubmed/16423985>Distinct role of macrophages in different tumor microenvironments.</a> <em>Cancer research</em> 66: 605--12.
			    </li>
			    <li id="Liao2009a">Liao Debbie, Luo Yunping, Markowitz Dorothy, Xiang Rong, Reisfeld Ralph a. (2009) <a href=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2775953\&tool=pmcentrez\&rendertype=abstract>Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model.</a> <em>PloS one</em> 4: e7965.
			    </li>
			    <li id="Mantovani1992">Mantovani a, Bottazzi B, Colotta F, Sozzani S, Ruco L. (1992) <a href=http://www.ncbi.nlm.nih.gov/pubmed/1388654>The origin and function of tumorassociated macrophages.</a> <em>Immunology today</em> 13: 265--70.
			    </li>
			    <li id="Meier-Schellersheim2006">Meier-Schellersheim Martin, Xu Xuehua, Angermann Bastian, Kunkel Eric J, Jin Tian, Germain Ronald N. (2006) <a href=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1513273\&tool=pmcentrez\&rendertype=abstract>Key role of local regulation in chemosensing revealed by a new molecular interactionbased modeling method.</a> <em>PLoS computational biology</em> 2: e82.
			    </li>
			    <li id="Mocellin2001">Mocellin S, Wang E, Marincola F M. (2001) <a href=http://www.ncbi.nlm.nih.gov/pubmed/11696695>Cytokines and immune response in the tumor microenvironment.</a> <em>Journal of immunotherapy</em> 24: 392--407.
			    </li>
			    <li id="Mocellin2005">Mocellin Simone, Mandruzzato Susanna, Zanovello Paola, Bronte Vincenzo. (2005) <a href=http://linkinghub.elsevier.com/retrieve/pii/S1740676505000234>Cancer rejection by the immune system Forcing the checkpoints of tumor immune escape.</a> <em>Drug Discovery Today: Disease Mechanisms</em> 2: 191--197.
			    </li>
			    <li id="Newell2012">Newell Evan W, Sigal Natalia, Bendall Sean C, Nolan Garry P, Davis Mark M. (2012) <a href=http://www.ncbi.nlm.nih.gov/pubmed/22265676>Cytometry by timeofflight shows combinatorial cytokine expression and virusspecific cell niches within a continuum of CD8 T cell phenotypes.</a> <em>Immunity</em> 36: 142--52.
			    </li>
			    <li id="Oppenheimer1996">Oppenheimer Joost, Fujiwara Hiromi. (1996) <a href=&nbsp;>The Role of Cytokines in Cancer.</a> <em>Cytokine \& growth factor reviews</em> 7: &nbsp;.
			    </li>
			    <li id="Quaranta2008">Quaranta Vito, Rejniak Katarzyna a, Gerlee Philip, Anderson Alexander R a. (2008) <a href=http://www.ncbi.nlm.nih.gov/pubmed/18524624>Invasion emerges from cancer cell adaptation to competitive microenvironments quantitative predictions from multiscale mathematical models.</a> <em>Seminars in cancer biology</em> 18: 338--48.
			    </li>
			    <li id="Ramis-Conde2008">Ramis-Conde Ignacio, a.J. Chaplain Mark, Anderson Alexander R.a.. (2008) <a href=http://linkinghub.elsevier.com/retrieve/pii/S0895717707001823>Mathematical modelling of cancer cell invasion of tissue.</a> <em>Mathematical and Computer Modelling</em> 47: 533--545.
			    </li>
			    <li id="Rosenkranz1985">Rosenkranz Gerd. (1985) <a href=&nbsp;>Growth Models with Stochastic Differential Equations An Example from Tumor Immunology.</a> <em>Mathematical biosciences</em> 186: 175--186.
			    </li>
			    <li id="Salazar-Onfray2007">Salazar-Onfray Flavio, Lopez Mercedes N, Mendoza-Naranjo Ariadna. (2007) <a href=http://www.ncbi.nlm.nih.gov/pubmed/17329145>Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape.</a> <em>Cytokine \& growth factor reviews</em> 18: 171--82.
			    </li>
			    <li id="Shurin2006">Shurin Michael R, Shurin Galina V, Lokshin Anna, Yurkovetsky Zoya R, Gutkin Dmitry W, Chatta Gurkamal, Zhong Hua, Han Baohui, Ferris Robert L. (2006) <a href=http://www.ncbi.nlm.nih.gov/pubmed/17029028>Intratumoral cytokineschemokinesgrowth factors and tumor infiltrating dendritic cells friends or enemies.</a> <em>Cancer metastasis reviews</em> 25: 333--56.
			    </li>
			    <li id="Smyth2001">Smyth M J, Godfrey D I, Trapani J a. (2001) <a href=http://www.ncbi.nlm.nih.gov/pubmed/11276199>A fresh look at tumor immunosurveillance and immunotherapy.</a> <em>Nature immunology</em> 2: 293--9.
			    </li>
			    <li id="Smyth2004">Smyth Mark J, Cretney Erika, Kershaw Michael H, Hayakawa Yoshihiro. (2004) <a href=http://www.ncbi.nlm.nih.gov/pubmed/15546400>Cytokines in cancer immunity and immunotherapy.</a> <em>Immunological reviews</em> 202: 275--93.
			    </li>
			    <li id="Tham2011">Tham Muly, Abastado Jean-Pierre. (2011) <a href=http://linkinghub.elsevier.com/retrieve/pii/S174067571100034X>Escape of tumor immune surveillance and metastasis.</a> <em>Drug Discovery Today: Disease Models</em> 8: 81--86.
			    </li>
			    <li id="Tracey1993">Tracey K J, Cerami a. (1993) <a href=http://www.ncbi.nlm.nih.gov/pubmed/8280464>Tumor necrosis factor other cytokines and disease.</a> <em>Annual review of cell biology</em> 9: 317--43.
			    </li>
			    <li id="Videla2012">Videla Santiago, Guziolowski Carito, Eduati Federica, Thiele Sven, Grabe Niels, Saez-Rodriguez Julio, Siegel Anne. (2012) <a href=&nbsp;>Revisiting the Training of Logic Models of Protein Signaling Networks with ASP.</a> <em>&nbsp;</em> &nbsp;: 342--361.
			    </li>
			    <li id="Wai2013">Wai Lu-En, Narang Vipin, Gouaillard Alexandre, Ng Lai Guan, Abastado Jean-Pierre. (2013) <a href=http://www.ncbi.nlm.nih.gov/pubmed/23651197>In silico modeling of cancer cell dissemination and metastasis.</a> <em>Annals of the New York Academy of Sciences</em> 1284: 71--4.
			    </li>
			    <li id="Webb2002">Webb Steven D, Sherratt Jonathan a, Fish Reginald G. (2002) <a href=http://www.ncbi.nlm.nih.gov/pubmed/12208611>Cells behaving badly a theoretical model for the FasFasL system in tumour immunology.</a> <em>Mathematical biosciences</em> 179: 113--29.
			    </li>
			    <li id="Wilson2002">Wilson Julia, Balkwill Fran. (2002) <a href=http://www.ncbi.nlm.nih.gov/pubmed/12027583>The role of cytokines in the epithelial cancer microenvironment.</a> <em>Seminars in cancer biology</em> 12: 113--20.
			    </li>
			    <li id="Wu2012">Wu Yu, Lu Yao, Chen Weiqiang, Fu Jianping, Fan Rong. (2012) <a href=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3271023\&tool=pmcentrez\&rendertype=abstract>In silico experimentation of glioma microenvironment development and antitumor therapy.</a> <em>PLoS computational biology</em> 8: e1002355.
			    </li>
			    <li id="Yiu2012">Yiu Hao Hong, Graham Andrea L, Stengel Robert F. (2012) <a href=http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3462188\&tool=pmcentrez\&rendertype=abstract>Dynamics of a cytokine storm.</a> <em>PloS one</em> 7: e45027.
			    </li>
			    <li id="Yu2007">Yu Hua, Kortylewski Marcin, Pardoll Drew. (2007) <a href=http://www.ncbi.nlm.nih.gov/pubmed/17186030>Crosstalk between cancer and immune cells role of STAT3 in the tumour microenvironment.</a> <em>Nature reviews. Immunology</em> 7: 41--51.
			    </li>
			    <li id="Zhou2010">Zhou Zuping, French Deborah L, Ma Ge, Eisenstein Samuel, Chen Ying, Divino Celia M, Keller Gordon, Chen Shu-Hsia, Pan Ping-Ying. (2010) <a href=http://www.ncbi.nlm.nih.gov/pubmed/20073041>Development and function of myeloidderived suppressor cells generated from mouse embryonic and hematopoietic stem cells.</a> <em>Stem cells (Dayton, Ohio)</em> 28: 620--32.
			    </li>
		    </ol>
		</div>
	<div id="toTop">
	  <a href="#mainContent"><img src="/static/images/totop2.png" alt="return to top"></a>
	</div>
</div>
            <div class="clear"></div>
			<div id="posts-footer">	<p>This entry is under category: <a href="../../projects/" title="category">projects</a>
</br>and was tagged as: <a href="../../tag/biology.html" title="tag">biology</a>, <a href="../../tag/research.html" title="tag">research</a>, <a href="../../tag/tiga.html" title="tag">TIGA</a>, <a href="../../tag/master.html" title="tag">master</a>,  and <a href="../../tag/master-thesis.html" title="tag">master thesis</a>.</p>
</div>
		</div>
		<div id="footer">
			<p>sndbx.be &#169; <a href="../../about/" title="Interested in learning more about this site?">2013</a> Powered by <a href="http://getpelican.com/" title="Pelican">Pelican</a></br>handcrafted by Emiliano Izquierdo</br>Last modified on 2013-10-22</p>
		</div>
<script type="text/javascript">


var myHeader = $('#my_fixable_header');
myHeader.data( 'position', myHeader.position() );
$(window).scroll(function(){
    var hPos = myHeader.data('position'), scroll = getScroll();
    $('#header-wrapper').css("-webkit-transform","translateY("+ (scroll.top/3) +"px)");
    $('#my_fixable_header').css("box-shadow", "0 5px 10px 0 #bbb");
    if ( hPos.top < scroll.top ){
        myHeader.addClass('fixed');
        $('#my_fixable_header').css("box-shadow", "0 5px 10px 0 #bbb");
        $('#mainContainer').css("margin","margin: 5px auto;");
    }
    else {
        myHeader.removeClass('fixed');
        $('#mainContainer').css("margin","margin: 0 auto;");
    }
    
    if (scroll.top < 200) {
      $('#my_fixable_header').css("opacity", (scroll.top * 0.005) );
      $('#header').css("opacity", ( 1- (scroll.top * 0.005)) );
       $('#nav').css("opacity", ( 1- (scroll.top * 0.005)) );
      $('#header-wrapper').css("background-color","rgba(204,255,0," + (scroll.top * 0.005) + ")");
    } else {
      $('#my_fixable_header').css("opacity", 1);
        $('#header-wrapper').css("background-color","rgba(204,255,0,1)");
    }
   
    
    if ( scroll.top == 0 ){
        $('#my_fixable_header').css("box-shadow", "none");
        $('#my_fixable_header').css("opacity", 0);
        $('#header').css("opacity", 1 );
       $('#nav').css("opacity", 1 );
        $('#header-wrapper').css("background-color","#fafafa");
    }
    
    
    
});

function getScroll () {
    var b = document.body;
    var e = document.documentElement;
    return {
        left: parseFloat( window.pageXOffset || b.scrollLeft || e.scrollLeft ),
        top: parseFloat( window.pageYOffset || b.scrollTop || e.scrollTop )
    };
}
    

</script>
		

    </body>
</html>